<DOC>
	<DOC>NCT02263261</DOC>
	<brief_summary>Use of a HADM and implant in post-mastectomy breast reconstruction.</brief_summary>
	<brief_title>Evaluation of a Human Acellular Dermal Matrix in Post Mastectomy Reconstruction</brief_title>
	<detailed_description>This is a prospective, single-site pilot study in which outcomes associated with the use of Flex HD® Pliable™ Perforated, Human Acellular Dermal Matrix and an implant which are used in post-mastectomy breast reconstruction will be obtained. The data collected will include reconstructive outcomes, aesthetic outcomes and patient-reported outcomes in order to ascertain advantages and disadvantages of using this particular HADM in post-mastectomy breast reconstruction.</detailed_description>
	<criteria>Scheduled to undergo a single or twostage, tissueassisted, implant breast reconstruction Mastectomy may be unilateral or bilateral, prophylactic or therapeutic Skin incision may be skin sparing, or nippleareolar sparing Have signed written, informed consent Be at least 18 years of age Patients undergoing autologous breast reconstruction Patients undergoing breast reconstruction following complications of breast augmentation, mastopexy, breast reduction, or breast conservation surgery (lumpectomy) Patients undergoing reconstruction after previously failed attempts at reconstruction Patients undergoing autologous breast reconstruction in conjunction with a tissue expander (such as a latissimus dorsi flap, DIEP flap) There will be no exclusions based on race or ethnicity BMI &gt; 40 Previous Radiation Treatment. Note: Postoperative radiation treatment does not exclude subjects from study continuation once enrolled.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>dermal matrix</keyword>
</DOC>